Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jun;99(6):944-956.
doi: 10.1111/cbdd.14043. Epub 2022 Apr 1.

Isoquinolines alkaloids and cancer metabolism: Pathways and targets to novel chemotherapy

Angélica Lauria do Nascimento Mello  1 , Patricia Zancan  1
Affiliations
Review

Isoquinolines alkaloids and cancer metabolism: Pathways and targets to novel chemotherapy

Angélica Lauria do Nascimento Mello et al. Chem Biol Drug Des. 2022 Jun.

Abstract

Cancer is one of the main causes of death in the world. This is a complex disease where the development of resistance to chemotherapy is frequent driving the search for new anticancer compounds. In this sense, isoquinolines have gained attention in the past few years. This review aims to highlight the new advances related to the use of isoquinolines compounds against cancer cells, and we point out targets for their anti-tumor action. Isoquinolines are compounds found in plants that are important for their protection. In cancer, many representatives of this class of compounds have demonstrated their efficacy against cancer by acting on cancer metabolism, such as triggering cell death, reducing pro-survival protein expression, inducing ROS production, inhibiting pro-survival cell signaling pathways, among other effects. The mechanisms triggered by isoquinolines in cancer cells represent robust anticancer strategies, which support that this class of compounds are strong candidates for cancer treatment.

Keywords: MAPK; NFκB; PI3K; cancer metabolism; cell death; isoquinolines.

PubMed Disclaimer

References

REFERENCES

    1. Abushouk, A. I., Salem, A. M. A., & Abdel-Daim, M. M. (2017). Berberis vulgaris for cardiovascular disorders: A scoping literature review. Iranian Journal of Basic Medical Sciences, 20(5), 503-510. https://doi.org/10.22038/IJBMS.2017.8674
    1. Alagesan, B., Contino, G., Guimaraes, A. R., Corcoran, R. B., Deshpande, V., Wojtkiewicz, G. R., Hezel, A. F., Wong, K.-K., Loda, M., Weissleder, R., Benes, C., Engelman, J. A., & Bardeesy, N. (2015). Combined MEK and PI3K inhibition in a mouse model of pancreatic cancer. Clinical Cancer Research, 21(2), 396-404. https://doi.org/10.1158/1078-0432.CCR-14-1591
    1. Altomare, D. A., & Testa, J. R. (2005). Perturbations of the AKT signaling pathway in human cancer. Oncogene, 24(50), 7455-7464. https://doi.org/10.1038/sj.onc.1209085
    1. Bortolot, C. S., Forezi, L. S. M., Marra, R. K. F., Reis, M. I. P., Sá, B. V. F., Filho, R. I., Ghasemishahrestani, Z., Sola-Penna, M., Zancan, P., Ferreira, V. F., & de C da Silva, F. (2019). Design, synthesis and biological evaluation of 1H-1,2,3-triazole-linked-1H-dibenzo[b,h]xanthenes as inductors of ROS-mediated apoptosis in the breast cancer cell line MCF-7. Medicinal Chemistry, 15(2), 119-129. https://doi.org/10.2174/1573406414666180524071409
    1. Branco, J. R., Oliveira, V. G., Esteves, A. M., Chipoline, I. C., Lima, M. F. O., Boechat, F. C. S., da Silva, F. C., Ferreira, V. F., Sola-Penna, M., de Souza, M. C. B. V., & Zancan, P. (2018). A novel naphthotriazolyl-4-oxoquinoline derivative that selectively controls breast cancer cells survival through the induction of apoptosis. Current Topics in Medicinal Chemistry, 18(17), 1465-1474. https://doi.org/10.2174/1568026618666180821142458

Publication types

LinkOut - more resources